- Does obesity increase the risk of hepatocellular carcinoma in chronic hepatitis B patients?
-
Jang BK
- KMID: 2373133
- Clin Mol Hepatol.
- 2016 Sep;22(3):336-338.
- doi: 10.3350/cmh.2016.0104
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma
-
Lee KB
- KMID: 2373142
- Clin Mol Hepatol.
- 2016 Sep;22(3):400-405.
- doi: 10.3350/cmh.2016.0105
A bile duct lesion originating from intrahepatic bile ducts is generally regarded as an incidental pathologic finding in liver specimens. However, a recent study on the molecular classification of intrahepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-alcoholic fatty liver diseases: update on the challenge of diagnosis and treatment
-
Oh H, Jun DW, Saeed WK, Nguyen MH
- KMID: 2373132
- Clin Mol Hepatol.
- 2016 Sep;22(3):327-335.
- doi: 10.3350/cmh.2016.0049
The prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to be 25-30% of the population, and is the most common cause of elevated liver enzymes in Korea. NAFLD is... -
- CITED
-
- Close
- SHARE
-
- Close
- What we need to know when performing and interpreting US elastography
-
Park SH, Kim SY, Suh CH, Lee SS, Kim KW, Lee SJ, Lee MG
- KMID: 2373143
- Clin Mol Hepatol.
- 2016 Sep;22(3):406-414.
- doi: 10.3350/cmh.2016.0106
According to the increasing need for accurate staging of hepatic fibrosis, the ultrasound (US) elastography techniques have evolved significantly over the past two decades. Currently, US elastography is increasingly used... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver transplantation for advanced hepatocellular carcinoma
-
Lee HW, Suh KS
- KMID: 2373130
- Clin Mol Hepatol.
- 2016 Sep;22(3):309-318.
- doi: 10.3350/cmh.2016.0042
There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded.... -
- CITED
-
- Close
- SHARE
-
- Close
- The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy
-
Varbobitis I, Papatheodoridis GV
- KMID: 2373131
- Clin Mol Hepatol.
- 2016 Sep;22(3):319-326.
- doi: 10.3350/cmh.2016.0045
Hepatocellular carcinoma (HCC) is a primary concern for patients with chronic hepatitis B (CHB). Antiviral therapy has been reasonably the focus of interest for HCC prevention, with most studies reporting... -
- CITED
-
- Close
- SHARE
-
- Close
- A Korean patient with Guillain-Barré syndrome following acute hepatitis E whose cholestasis resolved with steroid therapy
-
Ji SB, Lee SS, Jung HC, Kim HJ, Kim HJ, Kim TH, Jung WT, Lee OJ, Song DH
- KMID: 2373141
- Clin Mol Hepatol.
- 2016 Sep;22(3):396-399.
- doi: 10.3350/cmh.2015.0039
Autochthonous hepatitis E virus (HEV) is an emerging pathogen in developed countries, and several cases of acute HEV infection have been reported in South Korea. However, there have been no... -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC
- KMID: 2373140
- Clin Mol Hepatol.
- 2016 Sep;22(3):390-395.
- doi: 10.3350/cmh.2015.0050
Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression... -
- CITED
-
- Close
- SHARE
-
- Close
- Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis
-
Jeon Y, Jang ES, Choi YS, Kim JW, Jeong SH
- KMID: 2373136
- Clin Mol Hepatol.
- 2016 Sep;22(3):359-365.
- doi: 10.3350/cmh.2016.0033
BACKGROUND/AIMS: Glypican-3 (GPC3) protein is highly expressed in hepatocellular carcinoma (HCC) tissue. It has been suggested as a diagnostic biomarker, but its inconsistent performance means that it requires further assessment.... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the clinical outcomes between antiviral-naïve patients treated with entecavir and lamivudine-resistant patients receiving adefovir add-on lamivudine combination treatment
-
Kim HJ, Park SK, Yang HJ, Jung YS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI, Choi KY
- KMID: 2373135
- Clin Mol Hepatol.
- 2016 Sep;22(3):350-358.
- doi: 10.3350/cmh.2016.0019
BACKGROUND/AIMS: To analyze the effects of preexisting lamivudine (LAM) resistance and applying antiviral treatment (adefovir [ADV] add-on LAM combination treatment) on long-term treatment outcomes, and comparing the clinical outcomes of... -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis B surface antigen titer is a good indicator of durable viral response after entecavir off-treatment for chronic hepatitis B
-
Lee HA, Seo YS, Park SW, Park SJ, Kim TH, Suh SJ, Jung YK, Kim JH, An H, Yim HJ, Yeon JE, Byun KS, Um SH
- KMID: 2373139
- Clin Mol Hepatol.
- 2016 Sep;22(3):382-389.
- doi: 10.3350/cmh.2016.0047
BACKGROUND/AIMS: Clear indicators for stopping antiviral therapy in chronic hepatitis B (CHB) patients are not yet available. Since the level of hepatitis B surface antigen (HBsAg) is correlated with covalently... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
-
Kim JM, Lee KW, Song GW, Jung BH, Lee HW, Yi NJ, Kwon CD, Hwang S, Suh KS, Joh JW, Lee SK, Lee SG
- KMID: 2373137
- Clin Mol Hepatol.
- 2016 Sep;22(3):366-371.
- doi: 10.3350/cmh.2016.0022
BACKGROUND/AIMS: The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics... -
- CITED
-
- Close
- SHARE
-
- Close
- Decreased C-reactive protein induces abnormal vascular structure in a rat model of liver dysfunction induced by bile duct ligation
-
Jun JH, Choi JH, Bae SH, Oh SH, Kim GJ
- KMID: 2373138
- Clin Mol Hepatol.
- 2016 Sep;22(3):372-381.
- doi: 10.3350/cmh.2016.0032
BACKGROUND/AIMS: Chronic liver disease leads to liver fibrosis, and although the liver does have a certain regenerative capacity, this disease is associated with dysfunction of the liver vessels. C-reactive protein... -
- CITED
-
- Close
- SHARE
-
- Close
- Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
-
Lee J, Yoo SH, Sohn W, Kim HW, Choi YS, Won JH, Heo JY, Park SJ, Park YM
- KMID: 2373134
- Clin Mol Hepatol.
- 2016 Sep;22(3):339-349.
- doi: 10.3350/cmh.2016.0021
BACKGROUND/AIMS: This study aimed to clarify the effect of obesity on the development of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving antiviral treatment. METHODS: This study applied a... -
- CITED
-
- Close
- SHARE
-
- Close
